— Published 16 February 2022

Valieva would have taken three drugs

New revelation in the Kamila Valieva case. The New York Times reports that traces of three drugs, and not just one, were found in the positive sample of the Russian skater analysed by the Stockholm laboratory. In addition to trimetazidine, which has been on WADA’s list of banned drugs since 2014, the Swedish laboratory also detected traces of two other heart medications, hypoxene and L-carnitine. It should be noted that neither of these are banned by the World Anti-Doping Code. The American daily did not quote its source, but explained that its informant had taken part in the hearing of the young Russian at the end of last week before the ad hoc commission of the CAS in Beijing. According to Travis Tygart, the director of the US Anti-Doping Agency (USADA), the combination of these three substances could have the effect of “increasing endurance, reducing fatigue and promoting greater efficiency in using oxygen.” An American analysis impossible to confirm, or deny, at this stage of the case. Earlier in the day, on Tuesday 15 February, the Swiss Denis Oswald explained on behalf of the IOC that Kamila Valieva had justified her positive doping test by ingesting medication prescribed to her grandfather to treat a heart problem. The young Russian then took to the ice late in the evening for the short programme of the women’s figure skating event. Visibly nervous, she dominated the competition despite a poorly controlled landing of her triple axel. She then left the arena without answering questions from the media or attending the press conference. Kamila Valieva will compete in the free programme on Thursday 17 February. With, barring any failure, a very solid chance of winning the Olympic title at the age of 15.